Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration

Other authors

Institut Català de la Salut

Grup de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Bioméica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-02-02T09:55:11Z

2024-02-02T09:55:11Z

2024-04



Abstract

Topical ocular administration; Retinal neurodegeneration; Diabetes


Administración ocular tópica; Neurodegeneración de la retina; Diabetes


Administració ocular tòpica; Neurodegeneració de la retina; Diabetis


This work was funded by grants from the Instituto de Salud Carlos III (DTS18/0163 and ICI20/00129) and co-funded by European Union.

Document Type

Article


Published version

Language

English

Publisher

Wolters Kluwer Health

Related items

Neural Regeneration Research;19(4)

https://doi.org/10.4103/1673-5374.353492

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial-ShareAlike 4.0 International

http://creativecommons.org/licenses/by-nc-sa/4.0/

This item appears in the following Collection(s)